BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ng K, Mogul DB. Pediatric Liver Tumors. Clin Liver Dis 2018;22:753-72. [PMID: 30266161 DOI: 10.1016/j.cld.2018.06.008] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 5.5] [Reference Citation Analysis]
Number Citing Articles
1 Burenina OY, Lazarevich NL, Kustova IF, Shavochkina DA, Moroz EA, Kudashkin NE, Patyutko YI, Metelin AV, Kim EF, Skvortsov DA, Zatsepin TS, Rubtsova MP, Dontsova OA. Panel of potential lncRNA biomarkers can distinguish various types of liver malignant and benign tumors. J Cancer Res Clin Oncol 2021;147:49-59. [PMID: 32918630 DOI: 10.1007/s00432-020-03378-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
2 Hager J, Sergi CM. Hepatoblastoma. In: Sergi CM, editor. Liver Cancer. Exon Publications; 2021. pp. 145-64. [DOI: 10.36255/exonpublications.livercancer.2021.ch8] [Reference Citation Analysis]
3 Trézéguet V, Fatrouni H, Merched AJ. Immuno-Metabolic Modulation of Liver Oncogenesis by the Tryptophan Metabolism. Cells 2021;10:3469. [PMID: 34943977 DOI: 10.3390/cells10123469] [Reference Citation Analysis]
4 Regel I, Eichenmüller M, Mahajan UM, Hagl B, Benitz S, Häberle B, Vokuhl C, von Schweinitz D, Kappler R. Downregulation of SFRP1 is a protumorigenic event in hepatoblastoma and correlates with beta-catenin mutations. J Cancer Res Clin Oncol 2020;146:1153-67. [PMID: 32189106 DOI: 10.1007/s00432-020-03182-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Yang Z, Deng Y, Zhang K, Bai Y, Zhu J, Zhang J, Xin Y, Li L, He J, Wang W. LIN28B gene polymorphisms modify hepatoblastoma susceptibility in Chinese children. J Cancer 2020;11:3512-8. [PMID: 32284747 DOI: 10.7150/jca.42798] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
6 Vadlapudi SS, Srivastava A, Nishith N, Sarma MS, Poddar U, Pandey R. Spontaneous tumour lysis syndrome at presentation in an infant with hepatoblastoma: A rare occurrence. Pediatric Hematology Oncology Journal 2021;6:186-9. [DOI: 10.1016/j.phoj.2021.10.004] [Reference Citation Analysis]
7 Tschauner S, Riccabona M. [Imaging of hepatic tumors in children and adolescents]. Radiologe 2021;61:629-38. [PMID: 34061213 DOI: 10.1007/s00117-021-00851-1] [Reference Citation Analysis]
8 Chen ST, Han ZY, Ling P, Yu XL, Cheng ZG, Liu FY, Jiang H, Yu J. Percutaneous thermal ablation versus open liver resection for recurrent hepatoblastoma: a retrospective study. Int J Hyperthermia 2021;38:1086-91. [PMID: 34286633 DOI: 10.1080/02656736.2021.1941310] [Reference Citation Analysis]
9 Feng SG, Bhandari R, Ya L, Zhixuan B, Qiuhui P, Jiabei Z, Sewi M, Ni Z, Jing W, Fenyong S, Ji M, Bhandari R. SNHG9 promotes Hepatoblastoma Tumorigenesis via miR-23a-5p/Wnt3a Axis. J Cancer 2021;12:6031-49. [PMID: 34539877 DOI: 10.7150/jca.60748] [Reference Citation Analysis]
10 Fuchs J, Hoffmann K, Murtha-Lemekhova A, Kessler M, Günther P, Frongia G, Probst P, Mehrabi A. Establishing a Standardized Measure of Quality in Pediatric Liver Surgery: Definition and Validation of Textbook Outcome With Associated Predictors. Front Surg 2021;8:708351. [PMID: 34368218 DOI: 10.3389/fsurg.2021.708351] [Reference Citation Analysis]
11 Mitchell SG, Pencheva B, Westfall E, Porter CC. Cancer Predisposition in Neonates and Infants: Recognition, Tumor Types, and Surveillance. Clin Perinatol 2021;48:1-14. [PMID: 33583498 DOI: 10.1016/j.clp.2020.11.001] [Reference Citation Analysis]
12 Sintusek P, Phewplung T, Sanpavat A, Poovorawan Y. Liver tumors in children with chronic liver diseases. World J Gastrointest Oncol 2021; 13(11): 1680-1695 [PMID: 34853643 DOI: 10.4251/wjgo.v13.i11.1680] [Reference Citation Analysis]
13 Martins-Filho SN, Putra J. Hepatic mesenchymal hamartoma and undifferentiated embryonal sarcoma of the liver: a pathologic review. Hepat Oncol. 2020;7:HEP19. [PMID: 32647564 DOI: 10.2217/hep-2020-0002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
14 Li X, Wang H, Liu Z, Abudureyimu A. CircSETD3 (Hsa_circ_0000567) Suppresses Hepatoblastoma Pathogenesis via Targeting the miR-423-3p/Bcl-2-Interacting Mediator of Cell Death Axis. Front Genet 2021;12:724197. [PMID: 34659347 DOI: 10.3389/fgene.2021.724197] [Reference Citation Analysis]
15 Habibzadeh P, Ansari Asl M, Foroutan HR, Bahador A, Anbardar MH. Clinicopathological study of hepatic mesenchymal hamartoma and undifferentiated embryonal sarcoma of the liver: a single center study from Iran. Diagn Pathol 2021;16:55. [PMID: 34162402 DOI: 10.1186/s13000-021-01117-z] [Reference Citation Analysis]
16 Lucas B, Ravishankar S, Pateva I. Pediatric Primary Hepatic Tumors: Diagnostic Considerations. Diagnostics (Basel) 2021;11:333. [PMID: 33670452 DOI: 10.3390/diagnostics11020333] [Reference Citation Analysis]
17 Rodriguez-Gil JL, Bianconi SE, Farhat N, Kleiner DE, Nelson M, Porter FD. Hepatocellular carcinoma as a complication of Niemann-Pick disease type C1. Am J Med Genet A 2021. [PMID: 34138521 DOI: 10.1002/ajmg.a.62382] [Reference Citation Analysis]
18 Morin CE, Artunduaga M, Schooler GR, Brennan RC, Khanna G. Imaging for Staging of Pediatric Abdominal Tumors: An Update, From the AJR Special Series on Cancer Staging. AJR Am J Roentgenol 2021;:1-14. [PMID: 33825502 DOI: 10.2214/AJR.20.25310] [Reference Citation Analysis]
19 Zarfati A, Chambers G, Pio L, Guerin F, Fouquet V, Franchi-Abella S, Branchereau S. Management of focal nodular hyperplasia of the liver: Experience of 50 pediatric patients in a tertiary center. J Pediatr Surg 2020;55:1885-91. [PMID: 32057440 DOI: 10.1016/j.jpedsurg.2020.01.009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Kawahara I, Fukuzawa H, Urushihara N, Kosaka Y, Kuroda Y, Fujieda Y, Takeuchi Y, Uemura K, Iwade T, Samejima Y, Morita K, Maeda K. AFP-L3 as a Prognostic Predictor of Recurrence in Hepatoblastoma: A Pilot Study. J Pediatr Hematol Oncol 2021;43:e76-9. [PMID: 33093349 DOI: 10.1097/MPH.0000000000001971] [Reference Citation Analysis]
21 Wang G, Xie X, Chen H, Zhong Z, Zhou W, Jiang H, Xie X, Zhou L. Development of a pediatric liver CEUS criterion to classify benign and malignant liver lesions in pediatric patients: a pilot study. Eur Radiol 2021;31:6747-57. [PMID: 33666698 DOI: 10.1007/s00330-021-07784-2] [Reference Citation Analysis]
22 Francalanci P, Giovannoni I, De Stefanis C, Romito I, Grimaldi C, Castellano A, D'Oria V, Alaggio R, Alisi A. Focal Adhesion Kinase (FAK) Over-Expression and Prognostic Implication in Pediatric Hepatocellular Carcinoma. Int J Mol Sci 2020;21:E5795. [PMID: 32806748 DOI: 10.3390/ijms21165795] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
23 Moreira-silva H, Amorim J, Santos-silva E. Incidental Liver Lesions in children: a practical and evidence-based approach. Clinics and Research in Hepatology and Gastroenterology 2022. [DOI: 10.1016/j.clinre.2022.101904] [Reference Citation Analysis]
24 Karalexi MA, Servitzoglou M, Moschovi M, Moiseenko R, Bouka P, Ntzani E, Kachanov D, Petridou ET; NARECHEM-ST collaborative group., Moscow childhood liver tumor study group. Survival and prognostic factors for childhood malignant liver tumors: analysis of harmonized clinical data. Cancer Epidemiol 2021;70:101850. [PMID: 33220637 DOI: 10.1016/j.canep.2020.101850] [Reference Citation Analysis]